By Ama Sarfo ( September 6, 2012, 7:10 PM EDT) -- A Shire PLC subsidiary settled patent infringement claims Thursday against a Par Pharmaceutical Co. unit and TWi Pharmaceuticals Inc. over their plans to market a generic version of Shire's attention deficit hyperactivity drug, in a deal giving the generics makers licensing rights in 2016....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.